Skip to main content
In stock|Supportive Care (Antiemetic)

Dolasetron

Oncology TypeBoth (Solid & Hematologic)
Drug Class / Mechanism5-HT3 Receptor Antagonist
No Image
Description

Dolasetron is classified as a 5-HT3 Receptor Antagonist, sourced for use within our Supportive Care (Antiemetic) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategorySupportive Care (Antiemetic)
Oncology TypeBoth (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3